
In a Market Allergic to Quantum Hype, EcoSynQ Is Betting on Underpromising
Sceptics keep snake-oil dictionaries, short-sellers circle bold claims. One small company refuses the words everyone else chases — and stakes its credibility on a proof dossier it has yet to publish.




























